Research Article
Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19
| | Admission (n = 73) | n (%) | Involvement < 25% | Involvement 25–50% | Involvement > 50% |
| Unilateral ground-glass opacity | 8 (11.0) | 8 (100.0) | 0 (0.0) | 0 (0.0) | Bilateral ground-glass opacity | 58 (79.5) | 36 (62.1) | 16 (27.6) | 4 (6.9) |
| Discharge (n = 49) | Unilateral ground-glass opacity | 4 (8.1) | 4 (100.0) | 0 | 0 | Bilateral ground-glass opacity | 41 (83.6) | 20 (48.7) | 12 (29.2) | 9 (21.9) |
| | Admission | Discharge | Clear | 5 (6.8) | 2 (4.0) | Inflammatory nodules | 14 (19.2) | 11 (22.4) | Pleural effusion | 3 (4.1) | 3 (6.1) |
|
|